TP53 and hepatocellular carcinoma: However, given the well-established role of TP53 in tumor progression, genomic instability, and therapy resistance, additional studies with larger sample sizes and more refined molecular analyses are warranted to assess whether TP53 mutations contribute to survival disparities in specific HCC subtypes or therapeutic responses.